NEW YORK, Oct. 3 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Uroplasty Incorporated under the ticker symbol UPI. Based in Minneapolis, Minnesota, Uroplasty Inc. is a manufacturer and distributor of urological, otolaryngology, colon, rectal and plastic surgery implantable medical devices. The primary focus of the company's business is the marketing of an implantable device for the treatment of stress, urinary incontinence and vesicoureteral reflux. "We gladly welcome Uroplasty Incorporated to the American Stock Exchange," said John McGonegal, senior vice president of the Amex Equities Group. "Uroplasty joins the increasing number of innovative medical companies that have chosen to list here on the Amex, we look forward to working with the company to build increased investor attention in the marketplace." Uroplasty Inc. has selected Cohen Specialists LLC as its specialist. For further information on UPI and other Amex-listed companies, please visit http://www.amex.com/. The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 169 ETFs. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com/. DATASOURCE: The American Stock Exchange CONTACT: Javier E. David of American Stock Exchange, +1-212-306-1440, Web site: http://www.amex.com/

Copyright